Structure Therapeutics is trading at $22.95, up 8.87% from the October 16 regular-session close of $21.08; no verified company-specific announcement explaining the after-hours rise was found.
- Available reporting noted shares had recently touched a 52-week low.
- The regular-session decline came amid broader market weakness; however, major indices were down while Structure Therapeutics rose after hours, so market sentiment does not clearly explain the reversal.
- After-hours volume or activity details were unavailable in the sources reviewed.